D-Wave Quantum: Trump's Orders Make This Speculative Buy Worth Watching

D-Wave Quantum (QBTS) is rated Buy, but only for small, speculative positions because of high risk, overvaluation, negative EPS, and negative free cash flow. The bullish case is driven by recent U.S. executive orders that elevate quantum computing as a national security and procurement priority, potentially opening government contract opportunities. The company’s dual-platform approach—commercial annealing now and a gate-model roadmap later—supports the thesis despite weak current fundamentals.

Analysis

QBTS is becoming a policy-beta name as much as a technology story: the incremental upside is less about near-term commercial demand and more about whether federal procurement turns quantum from a lab budget line into a strategic line item. That favors the few public names with an obvious “domestic capability” narrative, but it also means the stock can rerate on headlines long before revenue inflects. The second-order effect is that a government-led funding wave could compress competition by privileging incumbents with security-clearance readiness, U.S. supply-chain localization, and auditability over pure technical elegance.

The main risk is that the market is extrapolating strategic importance faster than contracting reality. Quantum budgets are likely to move in lumpy, multi-year tranches, while investor time horizons are being priced in weeks; that mismatch usually creates sharp air pockets once the first round of enthusiasm fades. The business-model risk is that any progress in procurement may still not solve the valuation problem if dilution, R&D burn, and delayed commercialization keep per-share economics negative for several more quarters.

The contrarian read is that the move may be underdiscriminating between “national priority” and “near-term monetization.” A policy tailwind can expand TAM, but it does not guarantee that annealing-based systems become the default procurement choice if gate-based roadmaps keep absorbing capital without proof points. If the executive-order theme broadens to include multiple quantum vendors or adjacent defense contractors, QBTS could underperform the theme even while the sector rallies.

Key Decisions for Investors

• Trade QBTS as a tactical momentum/speculation name only: starter long on pullbacks over the next 1-3 weeks, with a hard stop if policy headlines fail to convert into contract announcements within 1-2 months.
• Prefer defined-risk upside via QBTS call spreads 2-4 months out rather than stock: captures headline convexity while limiting dilution/valuation drawdown if the procurement story stalls.
• Pair trade: long QBTS / short a broader unprofitable-tech basket over 4-8 weeks to isolate policy-driven beta; only keep if QBTS continues to outperform on defense/procurement news.
• If looking for cleaner exposure, express the theme through defense/compute infrastructure suppliers with procurement leverage rather than sole-name quantum risk; QBTS should be the highest-volatility sleeve, not the core position.
• Trim or hedge aggressively into any sharp 15-25% policy-driven spike unless accompanied by a signed federal pilot or contract — absent that, the risk/reward shifts quickly from asymmetric to crowded.